tradingkey.logo
搜索

Sanara Medtech Inc

SMTI
添加自选
33.860USD
-0.200-0.59%
收盘 07-31 16:00美东报价延迟15分钟
311.28M总市值
亏损市盈率 TTM

关于 Sanara Medtech Inc 公司

Sanara Medtech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. Its Sanara Surgical segment primarily markets and sells soft tissue repair and bone fusion products for use in the operating room or other sterile environments. Its Tissue Health Plus segment is focused on value-based wound care services. It markets and distributes CellerateRX Surgical Activated Collagen, FORTIFY TRG Tissue Repair Graft and FORTIFY FLOWABLE Extracellular Matrix as well as a portfolio of advanced biologic products focusing on ACTIGEN Verified Inductive Bone Matrix, ALLOCYTE Plus Advanced Viable Bone Matrix, BiFORM Bioactive Moldable Matrix, TEXAGEN Amniotic Membrane Allograft, and BIASURGE Advanced Surgical Solution to the surgical market. BIAKOS Antimicrobial Wound Gel and others are the products sold in the wound care market.

Sanara Medtech Inc简介

公司代码SMTI
公司名称Sanara Medtech Inc
上市日期Apr 07, 1994
CEOMuppalla (Suresh V)
员工数量141
证券类型Ordinary Share
年结日Apr 07
公司地址1200 Summit Avenue
城市FORT WORTH
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编76102
电话18175292300
网址https://sanaramedtech.com/
公司代码SMTI
上市日期Apr 07, 1994
CEOMuppalla (Suresh V)

Sanara Medtech Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
109.55K
-3.52%
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board
Executive Chairman of the Board
68.20K
+6.09%
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
26.86K
+15.47%
Ms. Sara N. Ortwein
Ms. Sara N. Ortwein
Independent Director
Independent Director
25.41K
+18.16%
Mr. Eric D. Tanzberger
Mr. Eric D. Tanzberger
Independent Director
Independent Director
22.97K
+23.11%
Mr. Eric D. Major
Mr. Eric D. Major
Independent Director
Independent Director
14.23K
+34.05%
Mr. Keith G. Myers
Mr. Keith G. Myers
Independent Director
Independent Director
9.32K
+47.02%
Mr. Suresh V. (Sam) Muppalla
Mr. Suresh V. (Sam) Muppalla
President and Chief Executive Officer of Tissue Health Plus, LLC
President and Chief Executive Officer of Tissue Health Plus, LLC
2.97K
--
Mr. Robert A. (Bob) DeSutter
Mr. Robert A. (Bob) DeSutter
Independent Director
Independent Director
--
--
Mr. Roszell Mack, III
Mr. Roszell Mack, III
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
109.55K
-3.52%
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board
Executive Chairman of the Board
68.20K
+6.09%
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
26.86K
+15.47%
Ms. Sara N. Ortwein
Ms. Sara N. Ortwein
Independent Director
Independent Director
25.41K
+18.16%
Mr. Eric D. Tanzberger
Mr. Eric D. Tanzberger
Independent Director
Independent Director
22.97K
+23.11%
Mr. Eric D. Major
Mr. Eric D. Major
Independent Director
Independent Director
14.23K
+34.05%

常见问题

Sanara Medtech Inc的前五大股东是谁?

Sanara Medtech Inc 的前五大股东如下:Mr. Seth D. Yon

有多少机构持有Sanara Medtech Inc(SMTI)的股份?

截至2026Q1,共有131家机构持有Sanara Medtech Inc的股份,合计持有的股份价值约为1.42M,占公司总股份的15.50%。与2025Q4相比,机构持股有所增加,增幅为-599767.00。

哪个业务部门对Sanara Medtech Inc的收入贡献最大?

在2026Q1,Soft tissue repair products业务部门对Sanara Medtech Inc的收入贡献最大,创收91.35M,占总收入的88.59%。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有